| 0 |
BENZODIAZEPINE DRUG LEVEL DECREASED |
7 |
0.4667 |
| 1 |
JEAVONS SYNDROME |
2 |
0.4000 |
| 2 |
AUTOIMMUNE APLASTIC ANAEMIA |
4 |
0.2857 |
| 3 |
CARNITINE ABNORMAL |
2 |
0.2500 |
| 4 |
ANTIMITOCHONDRIAL ANTIBODY |
2 |
0.2500 |
| 5 |
ATYPICAL ABSENCE SEIZURE |
1 |
0.2500 |
| 6 |
CONGENITAL CORNEAL ANOMALY |
1 |
0.1667 |
| 7 |
BENIGN ROLANDIC EPILEPSY |
4 |
0.1429 |
| 8 |
BRONCHIAL ASPIRATION PROCEDURE |
2 |
0.1111 |
| 9 |
CAMPTODACTYLY ACQUIRED |
1 |
0.0909 |
| 10 |
OROPHARYNGEAL OEDEMA |
13 |
0.0897 |
| 11 |
ABDOMINAL WALL CYST |
10 |
0.0820 |
| 12 |
CSF PROTEIN DECREASED |
1 |
0.0667 |
| 13 |
OCULOCEPHALOGYRIC REFLEX ABSENT |
3 |
0.0566 |
| 14 |
COMA BLISTER |
5 |
0.0556 |
| 15 |
BLEPHAROPHIMOSIS |
1 |
0.0526 |
| 16 |
DYSPROSODY |
1 |
0.0526 |
| 17 |
PSYCHOMOTOR DISADAPTATION SYNDROME |
2 |
0.0488 |
| 18 |
CONGENITAL NIPPLE ANOMALY |
1 |
0.0476 |
| 19 |
DRUG METABOLISING ENZYME TEST ABNORMAL |
1 |
0.0476 |
| 20 |
DEVELOPMENTAL REGRESSION |
6 |
0.0441 |
| 21 |
CSWS SYNDROME |
1 |
0.0435 |
| 22 |
BILE OUTPUT DECREASED |
1 |
0.0435 |
| 23 |
BARBITURATES POSITIVE |
3 |
0.0375 |
| 24 |
ACQUIRED MACROGLOSSIA |
3 |
0.0337 |
| 25 |
MULTIPLE-DRUG RESISTANCE |
104 |
0.0335 |
| 26 |
OPSOCLONUS MYOCLONUS |
7 |
0.0329 |
| 27 |
MYOCLONIC EPILEPSY |
49 |
0.0323 |
| 28 |
HYPERANDROGENISM |
3 |
0.0319 |
| 29 |
INTENTION TREMOR |
18 |
0.0317 |
| 30 |
GENERALISED NON-CONVULSIVE EPILEPSY |
1 |
0.0303 |
| 31 |
ATONIC SEIZURES |
25 |
0.0291 |
| 32 |
PLAGIOCEPHALY |
14 |
0.0281 |
| 33 |
AUTOMATISM EPILEPTIC |
1 |
0.0278 |
| 34 |
BODY DYSMORPHIC DISORDER |
10 |
0.0267 |
| 35 |
SWEAT GLAND DISORDER |
11 |
0.0262 |
| 36 |
PYLORIC STENOSIS |
21 |
0.0248 |
| 37 |
VESICOURETERIC REFLUX |
10 |
0.0247 |
| 38 |
ANAL ATRESIA |
13 |
0.0243 |
| 39 |
INTELLECTUAL DISABILITY |
36 |
0.0237 |
| 40 |
PETIT MAL EPILEPSY |
120 |
0.0235 |
| 41 |
TONIC CONVULSION |
33 |
0.0233 |
| 42 |
REYE'S SYNDROME |
2 |
0.0220 |
| 43 |
TRACHEO-OESOPHAGEAL FISTULA |
13 |
0.0203 |
| 44 |
SCLERODERMA-LIKE REACTION |
3 |
0.0190 |
| 45 |
POLYSEROSITIS |
8 |
0.0188 |
| 46 |
BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS |
3 |
0.0186 |
| 47 |
MACROGLOSSIA |
10 |
0.0182 |
| 48 |
EPIPHYSES DELAYED FUSION |
1 |
0.0182 |
| 49 |
DROPPED HEAD SYNDROME |
7 |
0.0177 |
| 50 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
13 |
0.0173 |
| 51 |
COMPLICATED FRACTURE |
1 |
0.0161 |
| 52 |
BULIMIA NERVOSA |
7 |
0.0159 |
| 53 |
CEREBELLAR ATROPHY |
14 |
0.0159 |
| 54 |
ARACHNODACTYLY |
1 |
0.0156 |
| 55 |
CONGENITAL EYELID MALFORMATION |
2 |
0.0155 |
| 56 |
ADRENOGENITAL SYNDROME |
2 |
0.0148 |
| 57 |
ACHLORHYDRIA |
1 |
0.0143 |
| 58 |
CHANGE IN SEIZURE PRESENTATION |
9 |
0.0139 |
| 59 |
CONGENITAL MUSCULOSKELETAL DISORDER OF SKULL |
1 |
0.0139 |
| 60 |
HEPATIC ADENOMA |
7 |
0.0135 |
| 61 |
CAMPTODACTYLY CONGENITAL |
1 |
0.0132 |
| 62 |
VAGAL NERVE STIMULATOR IMPLANTATION |
4 |
0.0131 |
| 63 |
SJS-TEN OVERLAP |
9 |
0.0128 |
| 64 |
CLEFT LIP AND PALATE |
13 |
0.0116 |
| 65 |
ANTICONVULSANT DRUG LEVEL ABNORMAL |
2 |
0.0114 |
| 66 |
BENZODIAZEPINE DRUG LEVEL INCREASED |
1 |
0.0105 |
| 67 |
PNEUMOCOCCAL INFECTION |
6 |
0.0101 |
| 68 |
ELECTROENCEPHALOGRAM ABNORMAL |
32 |
0.0101 |
| 69 |
DROP ATTACKS |
6 |
0.0101 |
| 70 |
EYELID MYOCLONUS |
1 |
0.0100 |
| 71 |
FOETAL VALPROATE SYNDROME |
1 |
0.0100 |
| 72 |
SEIZURE CLUSTER |
8 |
0.0097 |
| 73 |
PRODUCT ADMINISTRATION ISSUE |
2 |
0.0096 |
| 74 |
CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS |
1 |
0.0095 |
| 75 |
GENERALISED TONIC-CLONIC SEIZURE |
153 |
0.0092 |
| 76 |
ATROPHIC GLOSSITIS |
1 |
0.0092 |
| 77 |
FACIAL DYSMORPHISM |
2 |
0.0090 |
| 78 |
STATUS EPILEPTICUS |
102 |
0.0090 |
| 79 |
LENNOX-GASTAUT SYNDROME |
2 |
0.0088 |
| 80 |
PRECOCIOUS PUBERTY |
5 |
0.0088 |
| 81 |
CONGENITAL NEUROLOGICAL DISORDER |
1 |
0.0085 |
| 82 |
BEHAVIOUR DISORDER |
46 |
0.0085 |
| 83 |
DUPUYTREN'S CONTRACTURE |
1 |
0.0084 |
| 84 |
CHOANAL ATRESIA |
1 |
0.0083 |
| 85 |
APLASTIC ANAEMIA |
43 |
0.0082 |
| 86 |
BLOOD GROWTH HORMONE ABNORMAL |
1 |
0.0082 |
| 87 |
HYPERDYNAMIC LEFT VENTRICLE |
2 |
0.0081 |
| 88 |
ANTICONVULSANT DRUG LEVEL INCREASED |
13 |
0.0080 |
| 89 |
SELF-DESTRUCTIVE BEHAVIOUR |
7 |
0.0080 |
| 90 |
DISSOCIATIVE AMNESIA |
1 |
0.0077 |
| 91 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
5 |
0.0077 |
| 92 |
CONGENITAL ANOMALY IN OFFSPRING |
1 |
0.0076 |
| 93 |
ENZYME LEVEL DECREASED |
1 |
0.0076 |
| 94 |
HYDROCELE |
8 |
0.0075 |
| 95 |
ABDOMINAL WALL INFECTION |
1 |
0.0075 |
| 96 |
ALBUMIN GLOBULIN RATIO INCREASED |
1 |
0.0073 |
| 97 |
POSTURAL TREMOR |
2 |
0.0068 |
| 98 |
ATAXIA |
80 |
0.0067 |
| 99 |
MITRAL VALVE THICKENING |
2 |
0.0067 |
| 100 |
GLUCOSE URINE |
1 |
0.0067 |
| 101 |
HYPOSPADIAS |
12 |
0.0058 |
| 102 |
MITRAL VALVE DISEASE |
10 |
0.0056 |
| 103 |
COMPLEMENT FACTOR DECREASED |
1 |
0.0056 |
| 104 |
SUDDEN UNEXPLAINED DEATH IN EPILEPSY |
3 |
0.0056 |
| 105 |
DISSOCIATIVE DISORDER |
4 |
0.0055 |
| 106 |
DELUSIONAL DISORDER, UNSPECIFIED TYPE |
4 |
0.0053 |
| 107 |
COLOBOMA |
1 |
0.0053 |
| 108 |
BRAIN STEM SYNDROME |
4 |
0.0053 |
| 109 |
INFECTION REACTIVATION |
6 |
0.0052 |
| 110 |
DYSSOMNIA |
1 |
0.0052 |
| 111 |
HAEMANGIOMA |
12 |
0.0052 |
| 112 |
ENCOPRESIS |
1 |
0.0052 |
| 113 |
GRANULOCYTES ABNORMAL |
1 |
0.0050 |
| 114 |
AMMONIA ABNORMAL |
2 |
0.0050 |
| 115 |
ANHIDROSIS |
2 |
0.0049 |
| 116 |
LOW SET EARS |
2 |
0.0049 |
| 117 |
HALLUCINATION, OLFACTORY |
2 |
0.0046 |
| 118 |
CONGENITAL ORAL MALFORMATION |
1 |
0.0046 |
| 119 |
POLYDIPSIA |
18 |
0.0045 |
| 120 |
BLOOD ETHANOL INCREASED |
1 |
0.0045 |
| 121 |
LUPUS-LIKE SYNDROME |
41 |
0.0045 |
| 122 |
EPILEPTIC ENCEPHALOPATHY |
1 |
0.0045 |
| 123 |
PARVOVIRUS B19 INFECTION |
4 |
0.0045 |
| 124 |
NEUROMA |
2 |
0.0044 |
| 125 |
CHOREOATHETOSIS |
3 |
0.0044 |
| 126 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
2 |
0.0044 |
| 127 |
ANTICONVULSANT DRUG LEVEL DECREASED |
6 |
0.0042 |
| 128 |
CLONIC CONVULSION |
3 |
0.0041 |
| 129 |
DEVELOPMENTAL DELAY |
37 |
0.0041 |
| 130 |
CEREBRAL ARTERY STENOSIS |
2 |
0.0041 |
| 131 |
SUICIDAL BEHAVIOUR |
17 |
0.0041 |
| 132 |
PHIMOSIS |
3 |
0.0041 |
| 133 |
PROTEIN-LOSING GASTROENTEROPATHY |
2 |
0.0040 |
| 134 |
ERYTHEMA INFECTIOSUM |
1 |
0.0039 |
| 135 |
COOMBS TEST POSITIVE |
1 |
0.0037 |
| 136 |
EXCITABILITY |
1 |
0.0037 |
| 137 |
DEJA VU |
1 |
0.0036 |
| 138 |
PSEUDOLYMPHOMA |
2 |
0.0036 |
| 139 |
COMPLEX PARTIAL SEIZURES |
4 |
0.0036 |
| 140 |
CONGENITAL CARDIOVASCULAR ANOMALY |
3 |
0.0036 |
| 141 |
EXCESSIVE SKIN |
1 |
0.0035 |
| 142 |
EPILEPSY |
108 |
0.0035 |
| 143 |
ENZYME LEVEL INCREASED |
3 |
0.0035 |
| 144 |
GROSS MOTOR DELAY |
1 |
0.0035 |
| 145 |
BONE DEVELOPMENT ABNORMAL |
1 |
0.0035 |
| 146 |
FOOD INTERACTION |
6 |
0.0034 |
| 147 |
REFLUX GASTRITIS |
4 |
0.0033 |
| 148 |
CREATININE URINE INCREASED |
1 |
0.0033 |
| 149 |
EPIPHYSES PREMATURE FUSION |
1 |
0.0033 |
| 150 |
DECREASED EYE CONTACT |
1 |
0.0033 |
| 151 |
DISABILITY ASSESSMENT SCALE SCORE INCREASED |
1 |
0.0033 |
| 152 |
DEFIANT BEHAVIOUR |
1 |
0.0032 |
| 153 |
PRODUCT APPEARANCE CONFUSION |
3 |
0.0032 |
| 154 |
SEIZURE |
375 |
0.0032 |
| 155 |
HYPERAMMONAEMIA |
16 |
0.0032 |
| 156 |
DRUG LEVEL CHANGED |
2 |
0.0032 |
| 157 |
BREAST CELLULITIS |
1 |
0.0032 |
| 158 |
PRESSURE OF SPEECH |
2 |
0.0031 |
| 159 |
BREAST HAEMORRHAGE |
1 |
0.0030 |
| 160 |
REACTION TO EXCIPIENT |
7 |
0.0030 |
| 161 |
ABDOMINOPLASTY |
1 |
0.0030 |
| 162 |
AUTISM |
3 |
0.0030 |
| 163 |
POSTICTAL STATE |
3 |
0.0029 |
| 164 |
BRADYKINESIA |
17 |
0.0029 |
| 165 |
MYOCLONUS |
34 |
0.0028 |
| 166 |
HEART DISEASE CONGENITAL |
10 |
0.0028 |
| 167 |
DRUG-GENETIC INTERACTION |
1 |
0.0028 |
| 168 |
EXANTHEM |
1 |
0.0028 |
| 169 |
MULTIPLE CONGENITAL ABNORMALITIES |
4 |
0.0028 |
| 170 |
SOCIAL AVOIDANT BEHAVIOUR |
16 |
0.0028 |
| 171 |
EOSINOPHILIC COLITIS |
1 |
0.0027 |
| 172 |
OLIGURIA |
17 |
0.0027 |
| 173 |
AMINO ACID LEVEL INCREASED |
2 |
0.0027 |
| 174 |
VANISHING BILE DUCT SYNDROME |
3 |
0.0027 |
| 175 |
BK VIRUS INFECTION |
9 |
0.0027 |
| 176 |
CORNEAL REFLEX DECREASED |
1 |
0.0027 |
| 177 |
MUCOSAL HAEMORRHAGE |
3 |
0.0026 |
| 178 |
ASTROCYTOMA |
1 |
0.0025 |
| 179 |
GRAND MAL CONVULSION |
22 |
0.0024 |
| 180 |
AMAUROSIS |
2 |
0.0024 |
| 181 |
CORONA VIRUS INFECTION |
1 |
0.0023 |
| 182 |
LANGUAGE DISORDER |
5 |
0.0023 |
| 183 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
14 |
0.0023 |
| 184 |
RENAL TUBULAR ATROPHY |
2 |
0.0023 |
| 185 |
CONGENITAL MUSCULOSKELETAL ANOMALY |
1 |
0.0023 |
| 186 |
ANION GAP INCREASED |
3 |
0.0022 |
| 187 |
CLUMSINESS |
6 |
0.0022 |
| 188 |
CHRONIC FATIGUE SYNDROME |
3 |
0.0022 |
| 189 |
LUPUS NEPHRITIS |
4 |
0.0021 |
| 190 |
BREAST ENLARGEMENT |
7 |
0.0021 |
| 191 |
CEREBELLAR ATAXIA |
2 |
0.0021 |
| 192 |
HYPERVIGILANCE |
2 |
0.0021 |
| 193 |
DROWNING |
2 |
0.0020 |
| 194 |
AMMONIA INCREASED |
10 |
0.0020 |
| 195 |
BREAST CONSERVING SURGERY |
1 |
0.0020 |
| 196 |
POLYCYSTIC OVARIES |
3 |
0.0019 |
| 197 |
FLIGHT OF IDEAS |
1 |
0.0019 |
| 198 |
HYPOTONIA NEONATAL |
3 |
0.0019 |
| 199 |
PSYCHOMOTOR SKILLS IMPAIRED |
5 |
0.0019 |
| 200 |
HYPERKINESIA |
4 |
0.0019 |
| 201 |
DRUG LEVEL ABNORMAL |
1 |
0.0019 |
| 202 |
CONGENITAL NOSE MALFORMATION |
1 |
0.0019 |
| 203 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 204 |
EXECUTIVE DYSFUNCTION |
1 |
0.0018 |
| 205 |
BLOOD INSULIN INCREASED |
1 |
0.0018 |
| 206 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
8 |
0.0018 |
| 207 |
CYTOMEGALOVIRUS VIRAEMIA |
8 |
0.0018 |
| 208 |
DRUG RESISTANCE |
46 |
0.0018 |
| 209 |
ENCEPHALOMALACIA |
1 |
0.0018 |
| 210 |
DYSPRAXIA |
1 |
0.0018 |
| 211 |
APNOEIC ATTACK |
1 |
0.0018 |
| 212 |
GAZE PALSY |
3 |
0.0018 |
| 213 |
NEPHROTIC SYNDROME |
12 |
0.0017 |
| 214 |
HYDRONEPHROSIS |
13 |
0.0017 |
| 215 |
ENURESIS |
7 |
0.0017 |
| 216 |
ENTERAL NUTRITION |
1 |
0.0017 |
| 217 |
CHRONIC SPONTANEOUS URTICARIA |
2 |
0.0017 |
| 218 |
GINGIVAL HYPERPLASIA |
1 |
0.0017 |
| 219 |
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL |
1 |
0.0017 |
| 220 |
DYSMETRIA |
1 |
0.0017 |
| 221 |
AGGRESSION |
81 |
0.0016 |
| 222 |
ACUTE PULMONARY OEDEMA |
9 |
0.0016 |
| 223 |
HYPOTONIA |
16 |
0.0016 |
| 224 |
LIP HAEMORRHAGE |
2 |
0.0016 |
| 225 |
BODY HEIGHT BELOW NORMAL |
1 |
0.0016 |
| 226 |
PROCEDURAL HAEMORRHAGE |
6 |
0.0015 |
| 227 |
PARTIAL SEIZURES |
8 |
0.0015 |
| 228 |
PNEUMONIA STAPHYLOCOCCAL |
3 |
0.0015 |
| 229 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 230 |
NYSTAGMUS |
8 |
0.0015 |
| 231 |
LEARNING DISABILITY |
8 |
0.0015 |
| 232 |
TREATMENT FAILURE |
121 |
0.0015 |
| 233 |
CEREBRAL CYST |
1 |
0.0015 |
| 234 |
RASH MORBILLIFORM |
4 |
0.0014 |
| 235 |
NECROSIS |
8 |
0.0014 |
| 236 |
IMMUNE THROMBOCYTOPENIC PURPURA |
4 |
0.0014 |
| 237 |
ENCEPHALOPATHY |
34 |
0.0014 |
| 238 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 239 |
APALLIC SYNDROME |
1 |
0.0014 |
| 240 |
PULMONARY VALVE INCOMPETENCE |
2 |
0.0014 |
| 241 |
STRIDOR |
4 |
0.0014 |
| 242 |
GROWTH RETARDATION |
4 |
0.0014 |
| 243 |
THORACIC VERTEBRAL FRACTURE |
4 |
0.0014 |
| 244 |
HICCUPS |
11 |
0.0013 |
| 245 |
TOXIC EPIDERMAL NECROLYSIS |
20 |
0.0013 |
| 246 |
BRAIN OPERATION |
3 |
0.0013 |
| 247 |
EYELID DISORDER |
3 |
0.0013 |
| 248 |
CONVULSION |
74 |
0.0013 |
| 249 |
GRIMACING |
1 |
0.0013 |
| 250 |
BREAST FEEDING |
1 |
0.0013 |
| 251 |
MOTOR DYSFUNCTION |
13 |
0.0013 |
| 252 |
DYSMORPHISM |
3 |
0.0013 |
| 253 |
NEONATAL DISORDER |
2 |
0.0013 |
| 254 |
INAPPROPRIATE AFFECT |
2 |
0.0013 |
| 255 |
PATENT DUCTUS ARTERIOSUS |
5 |
0.0013 |
| 256 |
DISINHIBITION |
2 |
0.0012 |
| 257 |
STARING |
3 |
0.0012 |
| 258 |
POOR QUALITY PRODUCT ADMINISTERED |
13 |
0.0012 |
| 259 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0012 |
| 260 |
ANTINUCLEAR ANTIBODY POSITIVE |
4 |
0.0012 |
| 261 |
PRODUCT PREPARATION ISSUE |
8 |
0.0012 |
| 262 |
PSYCHOTIC DISORDER |
36 |
0.0012 |
| 263 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
1 |
0.0012 |
| 264 |
CSF PROTEIN INCREASED |
1 |
0.0012 |
| 265 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 266 |
ADRENAL SUPPRESSION |
1 |
0.0012 |
| 267 |
CONGENITAL CYSTIC KIDNEY DISEASE |
1 |
0.0012 |
| 268 |
ENTEROVIRUS INFECTION |
1 |
0.0012 |
| 269 |
GINGIVAL ERYTHEMA |
1 |
0.0012 |
| 270 |
CRANIOSYNOSTOSIS |
1 |
0.0012 |
| 271 |
ALTERED STATE OF CONSCIOUSNESS |
25 |
0.0012 |
| 272 |
KIDNEY FIBROSIS |
2 |
0.0012 |
| 273 |
AXONAL NEUROPATHY |
1 |
0.0011 |
| 274 |
AFFECTIVE DISORDER |
9 |
0.0011 |
| 275 |
PSYCHOMOTOR HYPERACTIVITY |
19 |
0.0011 |
| 276 |
FOOD REFUSAL |
1 |
0.0011 |
| 277 |
COGNITIVE DISORDER |
53 |
0.0011 |
| 278 |
DEPRESSIVE SYMPTOM |
4 |
0.0011 |
| 279 |
THINKING ABNORMAL |
21 |
0.0011 |
| 280 |
DRUG WITHDRAWAL CONVULSIONS |
2 |
0.0011 |
| 281 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 282 |
BLEPHAROSPASM |
7 |
0.0011 |
| 283 |
PRODUCT TASTE ABNORMAL |
15 |
0.0011 |
| 284 |
ABNORMAL WITHDRAWAL BLEEDING |
1 |
0.0011 |
| 285 |
ABULIA |
1 |
0.0011 |
| 286 |
AURA |
2 |
0.0011 |
| 287 |
PERFORMANCE STATUS DECREASED |
5 |
0.0011 |
| 288 |
HYPERTHERMIA |
8 |
0.0010 |
| 289 |
LYMPHADENOPATHY MEDIASTINAL |
2 |
0.0010 |
| 290 |
AGITATION NEONATAL |
1 |
0.0010 |
| 291 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 292 |
BLOOD URINE |
1 |
0.0010 |
| 293 |
THERAPEUTIC PRODUCT INEFFECTIVE |
4 |
0.0010 |
| 294 |
EYE MOVEMENT DISORDER |
7 |
0.0010 |
| 295 |
VENOUS THROMBOSIS |
4 |
0.0010 |
| 296 |
VOCAL CORD DISORDER |
2 |
0.0010 |
| 297 |
CEREBRAL ATROPHY |
4 |
0.0010 |
| 298 |
KLEBSIELLA INFECTION |
5 |
0.0010 |
| 299 |
BREAST ABSCESS |
1 |
0.0010 |
| 300 |
TALIPES |
3 |
0.0010 |
| 301 |
ABNORMAL BEHAVIOUR |
38 |
0.0010 |
| 302 |
PETECHIAE |
10 |
0.0010 |
| 303 |
LIVEDO RETICULARIS |
2 |
0.0010 |
| 304 |
DILATATION VENTRICULAR |
2 |
0.0010 |
| 305 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
4 |
0.0009 |
| 306 |
EYE CONTUSION |
2 |
0.0009 |
| 307 |
JOINT DISLOCATION |
10 |
0.0009 |
| 308 |
CUSHINGOID |
3 |
0.0009 |
| 309 |
FACIAL PALSY |
2 |
0.0009 |
| 310 |
FOETAL MALFORMATION |
1 |
0.0009 |
| 311 |
REACTION TO DRUG EXCIPIENTS |
2 |
0.0009 |
| 312 |
BIPOLAR I DISORDER |
2 |
0.0009 |
| 313 |
CONGENITAL ANOMALY |
7 |
0.0009 |
| 314 |
PELVIC FRACTURE |
7 |
0.0009 |
| 315 |
INCREASED APPETITE |
17 |
0.0009 |
| 316 |
MYOCARDITIS |
10 |
0.0009 |
| 317 |
DROOLING |
6 |
0.0009 |
| 318 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 319 |
BONE MARROW TOXICITY |
1 |
0.0008 |
| 320 |
MYOPIA |
2 |
0.0008 |
| 321 |
ENDOMETRIOSIS |
4 |
0.0008 |
| 322 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
33 |
0.0008 |
| 323 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 324 |
FEBRILE CONVULSION |
1 |
0.0008 |
| 325 |
SOMNOLENCE |
162 |
0.0008 |
| 326 |
GASTROINTESTINAL TUBE INSERTION |
2 |
0.0008 |
| 327 |
TOXIC ENCEPHALOPATHY |
4 |
0.0008 |
| 328 |
INCREASED BRONCHIAL SECRETION |
2 |
0.0008 |
| 329 |
THERAPY PARTIAL RESPONDER |
12 |
0.0008 |
| 330 |
BRADYPHRENIA |
5 |
0.0008 |
| 331 |
STEVENS-JOHNSON SYNDROME |
17 |
0.0008 |
| 332 |
AREFLEXIA |
2 |
0.0007 |
| 333 |
IRRITABILITY |
45 |
0.0007 |
| 334 |
CHEILITIS |
4 |
0.0007 |
| 335 |
DRUG INTERACTION |
117 |
0.0007 |
| 336 |
CALCULUS BLADDER |
1 |
0.0007 |
| 337 |
CLUSTER HEADACHE |
1 |
0.0007 |
| 338 |
ABNORMAL WEIGHT GAIN |
9 |
0.0007 |
| 339 |
DRUG LEVEL BELOW THERAPEUTIC |
4 |
0.0007 |
| 340 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
16 |
0.0007 |
| 341 |
INTRACRANIAL PRESSURE INCREASED |
4 |
0.0007 |
| 342 |
FANCONI SYNDROME |
1 |
0.0007 |
| 343 |
CATAPLEXY |
1 |
0.0007 |
| 344 |
AUDITORY DISORDER |
1 |
0.0007 |
| 345 |
SALIVARY HYPERSECRETION |
7 |
0.0007 |
| 346 |
TEARFULNESS |
3 |
0.0007 |
| 347 |
HYPOKINESIA |
10 |
0.0007 |
| 348 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 349 |
COMPLEX REGIONAL PAIN SYNDROME |
1 |
0.0007 |
| 350 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 351 |
WHEELCHAIR USER |
3 |
0.0007 |
| 352 |
HERNIA |
13 |
0.0007 |
| 353 |
PRODUCT ODOUR ABNORMAL |
7 |
0.0007 |
| 354 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
17 |
0.0007 |
| 355 |
ASTIGMATISM |
1 |
0.0007 |
| 356 |
PANIC ATTACK |
24 |
0.0007 |
| 357 |
JOINT INJURY |
14 |
0.0007 |
| 358 |
IMMUNE THROMBOCYTOPENIA |
3 |
0.0007 |
| 359 |
MATERNAL DRUGS AFFECTING FOETUS |
5 |
0.0007 |
| 360 |
CALCULUS URINARY |
1 |
0.0006 |
| 361 |
SEDATION |
17 |
0.0006 |
| 362 |
DAYDREAMING |
1 |
0.0006 |
| 363 |
LOCALISED OEDEMA |
3 |
0.0006 |
| 364 |
GENERALISED OEDEMA |
8 |
0.0006 |
| 365 |
POOR QUALITY DRUG ADMINISTERED |
4 |
0.0006 |
| 366 |
APATHY |
9 |
0.0006 |
| 367 |
HALLUCINATION, VISUAL |
13 |
0.0006 |
| 368 |
THROMBOTIC MICROANGIOPATHY |
6 |
0.0006 |
| 369 |
NIGHTMARE |
21 |
0.0006 |
| 370 |
DRUG LEVEL INCREASED |
10 |
0.0006 |
| 371 |
COLON CANCER |
9 |
0.0006 |
| 372 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
21 |
0.0006 |
| 373 |
FOOD AVERSION |
1 |
0.0006 |
| 374 |
TUBULOINTERSTITIAL NEPHRITIS |
11 |
0.0006 |
| 375 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
4 |
0.0006 |
| 376 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 377 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
32 |
0.0006 |
| 378 |
CHOREA |
1 |
0.0006 |
| 379 |
PRIAPISM |
2 |
0.0006 |
| 380 |
FAILURE TO THRIVE |
3 |
0.0006 |
| 381 |
HYPERTRANSAMINASAEMIA |
4 |
0.0006 |
| 382 |
AMENORRHOEA |
10 |
0.0006 |
| 383 |
FANCONI SYNDROME ACQUIRED |
1 |
0.0006 |
| 384 |
BLOOD LACTIC ACID INCREASED |
3 |
0.0006 |
| 385 |
GROIN PAIN |
5 |
0.0006 |
| 386 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
2 |
0.0006 |
| 387 |
ANGER |
19 |
0.0006 |
| 388 |
PRODUCT SUPPLY ISSUE |
4 |
0.0006 |
| 389 |
FRUSTRATION |
2 |
0.0006 |
| 390 |
PRODUCT SIZE ISSUE |
3 |
0.0006 |
| 391 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 392 |
DECREASED ACTIVITY |
6 |
0.0006 |
| 393 |
APPARENT DEATH |
2 |
0.0006 |
| 394 |
PREGNANCY |
11 |
0.0005 |
| 395 |
HYPERACUSIS |
2 |
0.0005 |
| 396 |
THERAPY NON-RESPONDER |
24 |
0.0005 |
| 397 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 398 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 399 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 400 |
OSTEOPENIA |
8 |
0.0005 |
| 401 |
LIPASE INCREASED |
4 |
0.0005 |
| 402 |
ATROPHY |
1 |
0.0005 |
| 403 |
BICYTOPENIA |
1 |
0.0005 |
| 404 |
GENE MUTATION |
1 |
0.0005 |
| 405 |
COORDINATION ABNORMAL |
7 |
0.0005 |
| 406 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
0.0005 |
| 407 |
DRUG LEVEL DECREASED |
5 |
0.0005 |
| 408 |
CYTOPENIA |
6 |
0.0005 |
| 409 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
2 |
0.0005 |
| 410 |
DYSARTHRIA |
18 |
0.0005 |
| 411 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 412 |
THERAPEUTIC RESPONSE CHANGED |
3 |
0.0005 |
| 413 |
DEPRESSED MOOD |
25 |
0.0005 |
| 414 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 415 |
SCREAMING |
3 |
0.0005 |
| 416 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
1 |
0.0005 |
| 417 |
IRRITABLE BOWEL SYNDROME |
10 |
0.0005 |
| 418 |
DIPLOPIA |
12 |
0.0005 |
| 419 |
PRODUCT PRESCRIBING ERROR |
11 |
0.0005 |
| 420 |
CEREBELLAR SYNDROME |
1 |
0.0005 |
| 421 |
CORNEAL DISORDER |
1 |
0.0005 |
| 422 |
DYSPHEMIA |
2 |
0.0005 |
| 423 |
APPETITE DISORDER |
3 |
0.0005 |
| 424 |
ADVERSE REACTION |
6 |
0.0005 |
| 425 |
PURPURA |
4 |
0.0005 |
| 426 |
FAECES PALE |
1 |
0.0004 |
| 427 |
ABORTION SPONTANEOUS |
18 |
0.0004 |
| 428 |
HEPATOTOXICITY |
10 |
0.0004 |
| 429 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 430 |
BRAIN FOG |
7 |
0.0004 |
| 431 |
DISTURBANCE IN ATTENTION |
24 |
0.0004 |
| 432 |
GASTRIC CANCER |
11 |
0.0004 |
| 433 |
HAIR GROWTH ABNORMAL |
3 |
0.0004 |
| 434 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
| 435 |
PHARMACEUTICAL PRODUCT COMPLAINT |
11 |
0.0004 |
| 436 |
RETCHING |
9 |
0.0004 |
| 437 |
PRE-ECLAMPSIA |
2 |
0.0004 |
| 438 |
SUICIDAL IDEATION |
38 |
0.0004 |
| 439 |
DERMATITIS BULLOUS |
3 |
0.0004 |
| 440 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 441 |
DRUG EXPOSURE DURING PREGNANCY |
14 |
0.0004 |
| 442 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 443 |
PSYCHIATRIC SYMPTOM |
3 |
0.0004 |
| 444 |
PARANOIA |
7 |
0.0004 |
| 445 |
PRESCRIBED UNDERDOSE |
8 |
0.0004 |
| 446 |
LEUKOPENIA |
20 |
0.0004 |
| 447 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 448 |
BRAIN INJURY |
4 |
0.0004 |
| 449 |
DERMATITIS ALLERGIC |
5 |
0.0004 |
| 450 |
EXCORIATION |
1 |
0.0004 |
| 451 |
DRUG INEFFECTIVE |
519 |
0.0004 |
| 452 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
28 |
0.0004 |
| 453 |
PHLEBITIS |
2 |
0.0004 |
| 454 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 455 |
INCREASED UPPER AIRWAY SECRETION |
2 |
0.0004 |
| 456 |
DIFFUSE LARGE B-CELL LYMPHOMA |
3 |
0.0004 |
| 457 |
HYPOALBUMINAEMIA |
3 |
0.0004 |
| 458 |
INTENTIONAL DOSE OMISSION |
11 |
0.0004 |
| 459 |
FOETAL DEATH |
2 |
0.0004 |
| 460 |
LETHARGY |
22 |
0.0004 |
| 461 |
CATATONIA |
2 |
0.0004 |
| 462 |
TRICUSPID VALVE INCOMPETENCE |
3 |
0.0004 |
| 463 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 464 |
SKIN LACERATION |
4 |
0.0004 |
| 465 |
SLEEP APNOEA SYNDROME |
7 |
0.0004 |
| 466 |
TIC |
2 |
0.0004 |
| 467 |
MOOD ALTERED |
10 |
0.0004 |
| 468 |
GINGIVAL BLEEDING |
5 |
0.0004 |
| 469 |
DECREASED APPETITE |
85 |
0.0004 |
| 470 |
CLONUS |
1 |
0.0004 |
| 471 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 472 |
PRESCRIBED OVERDOSE |
7 |
0.0004 |
| 473 |
DYSTONIA |
7 |
0.0004 |
| 474 |
INTERMENSTRUAL BLEEDING |
2 |
0.0004 |
| 475 |
PANCYTOPENIA |
20 |
0.0004 |
| 476 |
ASPARTATE AMINOTRANSFERASE INCREASED |
19 |
0.0004 |
| 477 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 478 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 479 |
FACE OEDEMA |
6 |
0.0004 |
| 480 |
GYNAECOMASTIA |
11 |
0.0004 |
| 481 |
CONDITION AGGRAVATED |
107 |
0.0004 |
| 482 |
IMPAIRED DRIVING ABILITY |
4 |
0.0004 |
| 483 |
VITAMIN D DECREASED |
3 |
0.0004 |
| 484 |
UNRESPONSIVE TO STIMULI |
9 |
0.0003 |
| 485 |
VISUAL DISTURBANCE |
2 |
0.0003 |
| 486 |
HEAD INJURY |
11 |
0.0003 |
| 487 |
TREATMENT NONCOMPLIANCE |
19 |
0.0003 |
| 488 |
FIBULA FRACTURE |
1 |
0.0003 |
| 489 |
MOOD SWINGS |
11 |
0.0003 |
| 490 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 491 |
DYSKINESIA |
14 |
0.0003 |
| 492 |
METABOLIC DISORDER |
2 |
0.0003 |
| 493 |
ABORTION |
1 |
0.0003 |
| 494 |
DECREASED INTEREST |
2 |
0.0003 |
| 495 |
DRUG ERUPTION |
6 |
0.0003 |
| 496 |
BRAIN HERNIATION |
1 |
0.0003 |
| 497 |
MUSCLE RIGIDITY |
4 |
0.0003 |
| 498 |
WITHDRAWAL SYNDROME |
14 |
0.0003 |
| 499 |
CRANIOCEREBRAL INJURY |
1 |
0.0003 |
| 500 |
PRODUCT SUBSTITUTION ISSUE |
19 |
0.0003 |
| 501 |
EYE INJURY |
1 |
0.0003 |
| 502 |
AGITATION |
24 |
0.0003 |
| 503 |
RESPIRATORY DISTRESS |
9 |
0.0003 |
| 504 |
ECTOPIC PREGNANCY |
1 |
0.0003 |
| 505 |
PERSONALITY CHANGE |
3 |
0.0003 |
| 506 |
BLISTER |
18 |
0.0003 |
| 507 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 508 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 509 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
9 |
0.0003 |
| 510 |
PRODUCT USE COMPLAINT |
5 |
0.0003 |
| 511 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 512 |
HYPERSOMNIA |
9 |
0.0003 |
| 513 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 514 |
ANOREXIA |
4 |
0.0003 |
| 515 |
REFUSAL OF TREATMENT BY PATIENT |
2 |
0.0003 |
| 516 |
MENORRHAGIA |
6 |
0.0003 |
| 517 |
BEDRIDDEN |
4 |
0.0003 |
| 518 |
MANIA |
5 |
0.0003 |
| 519 |
MUSCLE TWITCHING |
7 |
0.0003 |
| 520 |
TREMOR |
50 |
0.0003 |
| 521 |
ANXIETY DISORDER |
1 |
0.0003 |
| 522 |
DRUG TOXICITY |
4 |
0.0003 |
| 523 |
ACUTE HEPATIC FAILURE |
4 |
0.0003 |
| 524 |
RESPIRATION ABNORMAL |
2 |
0.0003 |
| 525 |
MENTAL IMPAIRMENT |
7 |
0.0003 |
| 526 |
DRUG-INDUCED LIVER INJURY |
9 |
0.0003 |
| 527 |
SPEECH DISORDER |
15 |
0.0003 |
| 528 |
BRONCHIOLITIS |
1 |
0.0003 |
| 529 |
HAND FRACTURE |
2 |
0.0003 |
| 530 |
HEPATOCELLULAR INJURY |
4 |
0.0003 |
| 531 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 532 |
BODY HEIGHT DECREASED |
3 |
0.0003 |
| 533 |
OFF LABEL USE |
245 |
0.0003 |
| 534 |
ELECTROCARDIOGRAM QT PROLONGED |
10 |
0.0003 |
| 535 |
GASTROENTERITIS VIRAL |
5 |
0.0003 |
| 536 |
TONGUE DISORDER |
2 |
0.0003 |
| 537 |
CRYING |
10 |
0.0003 |
| 538 |
CHOLELITHIASIS |
9 |
0.0003 |
| 539 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 540 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 541 |
ANGIOEDEMA |
12 |
0.0003 |
| 542 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 543 |
FOOT DEFORMITY |
3 |
0.0003 |
| 544 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 545 |
GAIT DISTURBANCE |
51 |
0.0003 |
| 546 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 547 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 548 |
APHASIA |
8 |
0.0003 |
| 549 |
FRACTURE |
5 |
0.0003 |
| 550 |
POLLAKIURIA |
11 |
0.0003 |
| 551 |
ACIDOSIS |
2 |
0.0003 |
| 552 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 553 |
HYPOKALAEMIA |
12 |
0.0003 |
| 554 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 555 |
FOOD ALLERGY |
2 |
0.0003 |
| 556 |
RASH PRURITIC |
14 |
0.0003 |
| 557 |
CAESAREAN SECTION |
3 |
0.0003 |
| 558 |
CHOKING |
5 |
0.0003 |
| 559 |
HYPOXIA |
9 |
0.0003 |
| 560 |
LYMPHADENOPATHY |
9 |
0.0003 |
| 561 |
BACTERAEMIA |
3 |
0.0003 |
| 562 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 563 |
ACCIDENT |
3 |
0.0003 |
| 564 |
HYPOTHYROIDISM |
8 |
0.0003 |
| 565 |
MYELOSUPPRESSION |
9 |
0.0002 |
| 566 |
TRANSPLANT REJECTION |
2 |
0.0002 |
| 567 |
NERVOUSNESS |
13 |
0.0002 |
| 568 |
HYPONATRAEMIA |
14 |
0.0002 |
| 569 |
SENSORY LOSS |
2 |
0.0002 |
| 570 |
DRUG EFFECT INCOMPLETE |
9 |
0.0002 |
| 571 |
INTENTIONAL SELF-INJURY |
5 |
0.0002 |
| 572 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 573 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 574 |
GALLBLADDER OPERATION |
1 |
0.0002 |
| 575 |
MATERNAL EXPOSURE DURING PREGNANCY |
22 |
0.0002 |
| 576 |
ALANINE AMINOTRANSFERASE INCREASED |
15 |
0.0002 |
| 577 |
GOITRE |
1 |
0.0002 |
| 578 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 579 |
SECRETION DISCHARGE |
3 |
0.0002 |
| 580 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 581 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 582 |
MYDRIASIS |
3 |
0.0002 |
| 583 |
WEIGHT INCREASED |
52 |
0.0002 |
| 584 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 585 |
DRUG INTOLERANCE |
22 |
0.0002 |
| 586 |
GALLBLADDER DISORDER |
4 |
0.0002 |
| 587 |
RESPIRATORY FAILURE |
16 |
0.0002 |
| 588 |
LUNG NEOPLASM MALIGNANT |
9 |
0.0002 |
| 589 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 590 |
EAR DISORDER |
1 |
0.0002 |
| 591 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 592 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 593 |
HEPATIC FUNCTION ABNORMAL |
8 |
0.0002 |
| 594 |
SLEEP DISORDER |
15 |
0.0002 |
| 595 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 596 |
VOMITING |
98 |
0.0002 |
| 597 |
AFFECT LABILITY |
2 |
0.0002 |
| 598 |
ATELECTASIS |
2 |
0.0002 |
| 599 |
FINGER DEFORMITY |
1 |
0.0002 |
| 600 |
LIVER FUNCTION TEST ABNORMAL |
6 |
0.0002 |
| 601 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 602 |
LIVER INJURY |
5 |
0.0002 |
| 603 |
HEPATOMEGALY |
2 |
0.0002 |
| 604 |
INTENTIONAL OVERDOSE |
13 |
0.0002 |
| 605 |
ABASIA |
5 |
0.0002 |
| 606 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 607 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 608 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 609 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 610 |
UPPER LIMB FRACTURE |
4 |
0.0002 |
| 611 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 612 |
GENERAL PHYSICAL HEALTH DETERIORATION |
23 |
0.0002 |
| 613 |
PRODUCT PHYSICAL ISSUE |
4 |
0.0002 |
| 614 |
SUICIDE ATTEMPT |
12 |
0.0002 |
| 615 |
NEPHROLITHIASIS |
9 |
0.0002 |
| 616 |
INSURANCE ISSUE |
3 |
0.0002 |
| 617 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 618 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 619 |
CYANOSIS |
3 |
0.0002 |
| 620 |
ABDOMINAL PAIN UPPER |
39 |
0.0002 |
| 621 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 622 |
HALLUCINATION, AUDITORY |
3 |
0.0002 |
| 623 |
OBESITY |
3 |
0.0002 |
| 624 |
EAR INFECTION |
5 |
0.0002 |
| 625 |
EATING DISORDER |
4 |
0.0002 |
| 626 |
BREAST PAIN |
2 |
0.0002 |
| 627 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 628 |
POOR QUALITY SLEEP |
4 |
0.0002 |
| 629 |
PRODUCT USE IN UNAPPROVED INDICATION |
46 |
0.0002 |
| 630 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 631 |
BACK INJURY |
2 |
0.0002 |
| 632 |
TOXICITY TO VARIOUS AGENTS |
31 |
0.0002 |
| 633 |
PALLOR |
5 |
0.0002 |
| 634 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 635 |
ASPIRATION |
2 |
0.0002 |
| 636 |
FAECALOMA |
1 |
0.0002 |
| 637 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 638 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 639 |
RESPIRATORY ARREST |
5 |
0.0002 |
| 640 |
DENTAL CARIES |
2 |
0.0002 |
| 641 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 642 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 643 |
LOSS OF CONSCIOUSNESS |
23 |
0.0002 |
| 644 |
FEELING HOT |
11 |
0.0002 |
| 645 |
THROMBOCYTOPENIA |
20 |
0.0002 |
| 646 |
MALNUTRITION |
2 |
0.0002 |
| 647 |
ANGIOPATHY |
1 |
0.0002 |
| 648 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 649 |
EXPOSURE DURING PREGNANCY |
11 |
0.0002 |
| 650 |
REBOUND EFFECT |
2 |
0.0002 |
| 651 |
DISORIENTATION |
7 |
0.0002 |
| 652 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 653 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 654 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 655 |
HALLUCINATION |
13 |
0.0002 |
| 656 |
FOETAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 657 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 658 |
EYELID OEDEMA |
2 |
0.0002 |
| 659 |
WEIGHT DECREASED |
48 |
0.0002 |
| 660 |
SPLENOMEGALY |
2 |
0.0002 |
| 661 |
BRADYCARDIA |
9 |
0.0002 |
| 662 |
URINARY INCONTINENCE |
5 |
0.0002 |
| 663 |
DYSPHAGIA |
16 |
0.0002 |
| 664 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 665 |
HEPATIC FAILURE |
5 |
0.0002 |
| 666 |
RESTLESS LEGS SYNDROME |
3 |
0.0002 |
| 667 |
THERAPEUTIC RESPONSE DECREASED |
10 |
0.0002 |
| 668 |
NOCTURIA |
2 |
0.0002 |
| 669 |
HYPERGLYCAEMIA |
6 |
0.0002 |
| 670 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 671 |
DEPRESSION |
37 |
0.0002 |
| 672 |
HYPOACUSIS |
7 |
0.0002 |
| 673 |
FALL |
54 |
0.0002 |
| 674 |
EMOTIONAL DISORDER |
5 |
0.0002 |
| 675 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 676 |
CHOLANGITIS |
1 |
0.0002 |
| 677 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 678 |
NO ADVERSE EVENT |
29 |
0.0002 |
| 679 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 680 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 681 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 682 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 683 |
DRUG PRESCRIBING ERROR |
3 |
0.0002 |
| 684 |
THERAPEUTIC RESPONSE UNEXPECTED |
7 |
0.0002 |
| 685 |
GALACTORRHOEA |
1 |
0.0002 |
| 686 |
LOWER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 687 |
DYSPEPSIA |
15 |
0.0002 |
| 688 |
DYSGRAPHIA |
1 |
0.0002 |
| 689 |
STAPHYLOCOCCAL INFECTION |
5 |
0.0002 |
| 690 |
PANCREATITIS |
8 |
0.0002 |
| 691 |
SPINAL FRACTURE |
3 |
0.0001 |
| 692 |
JAUNDICE |
4 |
0.0001 |
| 693 |
OEDEMA PERIPHERAL |
18 |
0.0001 |
| 694 |
BONE MARROW FAILURE |
3 |
0.0001 |
| 695 |
COMA |
7 |
0.0001 |
| 696 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 697 |
PRODUCT DOSE OMISSION ISSUE |
43 |
0.0001 |
| 698 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 699 |
FATIGUE |
113 |
0.0001 |
| 700 |
ENCEPHALITIS |
1 |
0.0001 |
| 701 |
EXTRASYSTOLES |
1 |
0.0001 |
| 702 |
LYMPHOPENIA |
2 |
0.0001 |
| 703 |
RASH |
61 |
0.0001 |
| 704 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 705 |
AMNESIA |
9 |
0.0001 |
| 706 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
5 |
0.0001 |
| 707 |
DYSSTASIA |
4 |
0.0001 |
| 708 |
MIGRAINE |
13 |
0.0001 |
| 709 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 710 |
ARTHROPOD BITE |
1 |
0.0001 |
| 711 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 712 |
FEELING DRUNK |
1 |
0.0001 |
| 713 |
GASTROINTESTINAL DISORDER |
12 |
0.0001 |
| 714 |
EPISTAXIS |
10 |
0.0001 |
| 715 |
PRODUCT USE ISSUE |
25 |
0.0001 |
| 716 |
HYPERHIDROSIS |
17 |
0.0001 |
| 717 |
INSOMNIA |
35 |
0.0001 |
| 718 |
MEMORY IMPAIRMENT |
18 |
0.0001 |
| 719 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 720 |
TINNITUS |
6 |
0.0001 |
| 721 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 722 |
ADVERSE EVENT |
12 |
0.0001 |
| 723 |
THYROID DISORDER |
2 |
0.0001 |
| 724 |
APHTHOUS ULCER |
1 |
0.0001 |
| 725 |
APNOEA |
1 |
0.0001 |
| 726 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 727 |
DIZZINESS |
64 |
0.0001 |
| 728 |
INJURY |
9 |
0.0001 |
| 729 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 730 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 731 |
DECUBITUS ULCER |
1 |
0.0001 |
| 732 |
ALOPECIA |
24 |
0.0001 |
| 733 |
MULTIPLE FRACTURES |
2 |
0.0001 |
| 734 |
OSTEOPOROSIS |
5 |
0.0001 |
| 735 |
FEELING ABNORMAL |
29 |
0.0001 |
| 736 |
LIP SWELLING |
4 |
0.0001 |
| 737 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 738 |
RHABDOMYOLYSIS |
5 |
0.0001 |
| 739 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 740 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 741 |
HAEMATEMESIS |
3 |
0.0001 |
| 742 |
HEMIPARESIS |
2 |
0.0001 |
| 743 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 744 |
HYPOPHAGIA |
3 |
0.0001 |
| 745 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 746 |
ANURIA |
1 |
0.0001 |
| 747 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 748 |
CARDIAC MURMUR |
1 |
0.0001 |
| 749 |
ILL-DEFINED DISORDER |
7 |
0.0001 |
| 750 |
LOCAL SWELLING |
2 |
0.0001 |
| 751 |
EOSINOPHILIA |
2 |
0.0001 |
| 752 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 753 |
GASTRITIS |
3 |
0.0001 |
| 754 |
HEADACHE |
71 |
0.0001 |
| 755 |
LIVER DISORDER |
5 |
0.0001 |
| 756 |
FEAR |
3 |
0.0001 |
| 757 |
CONFUSIONAL STATE |
18 |
0.0001 |
| 758 |
ADVERSE DRUG REACTION |
10 |
0.0001 |
| 759 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 760 |
THROAT TIGHTNESS |
3 |
0.0001 |
| 761 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 762 |
RESTLESSNESS |
4 |
0.0001 |
| 763 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 764 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 765 |
ABDOMINAL PAIN |
25 |
0.0001 |
| 766 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 767 |
APPENDICITIS |
1 |
0.0001 |
| 768 |
DEFORMITY |
1 |
0.0001 |
| 769 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 770 |
PYREXIA |
37 |
0.0001 |
| 771 |
CHOLESTASIS |
2 |
0.0001 |
| 772 |
BALANCE DISORDER |
9 |
0.0001 |
| 773 |
HYPOGLYCAEMIA |
5 |
0.0001 |
| 774 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 775 |
TACHYCARDIA |
9 |
0.0001 |
| 776 |
SINUS DISORDER |
2 |
0.0001 |
| 777 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 778 |
FEEDING DISORDER |
2 |
0.0001 |
| 779 |
EYELID PTOSIS |
1 |
0.0001 |
| 780 |
EUPHORIC MOOD |
1 |
0.0001 |
| 781 |
ROAD TRAFFIC ACCIDENT |
4 |
0.0001 |
| 782 |
URTICARIA |
16 |
0.0001 |
| 783 |
NAUSEA |
73 |
0.0001 |
| 784 |
OEDEMA |
5 |
0.0001 |
| 785 |
MENTAL DISORDER |
4 |
0.0001 |
| 786 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 787 |
ACUTE KIDNEY INJURY |
14 |
0.0001 |
| 788 |
INTENTIONAL PRODUCT USE ISSUE |
8 |
0.0001 |
| 789 |
EYE DISORDER |
3 |
0.0001 |
| 790 |
VIRAL INFECTION |
3 |
0.0001 |
| 791 |
DEHYDRATION |
12 |
0.0001 |
| 792 |
MEDICATION ERROR |
5 |
0.0001 |
| 793 |
TOOTH DISORDER |
2 |
0.0001 |
| 794 |
URINARY RETENTION |
3 |
0.0001 |
| 795 |
HYPOTENSION |
18 |
0.0001 |
| 796 |
ORAL PAIN |
2 |
0.0001 |
| 797 |
SNEEZING |
2 |
0.0001 |
| 798 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 799 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 800 |
VISUAL IMPAIRMENT |
11 |
0.0001 |
| 801 |
EYE INFECTION |
1 |
0.0001 |
| 802 |
ANXIETY |
25 |
0.0001 |
| 803 |
ILLNESS |
9 |
0.0001 |
| 804 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 805 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 806 |
ANAEMIA |
16 |
0.0001 |
| 807 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 808 |
OVERDOSE |
18 |
0.0001 |
| 809 |
RENAL IMPAIRMENT |
7 |
0.0001 |
| 810 |
DIARRHOEA |
53 |
0.0001 |
| 811 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 812 |
DYSURIA |
3 |
0.0001 |
| 813 |
PNEUMONIA |
26 |
0.0001 |
| 814 |
VISION BLURRED |
11 |
0.0001 |
| 815 |
ABDOMINAL DISCOMFORT |
13 |
0.0001 |
| 816 |
BACK PAIN |
18 |
0.0001 |
| 817 |
HAEMATOMA |
2 |
0.0001 |
| 818 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 819 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
| 820 |
URINARY TRACT INFECTION |
13 |
0.0001 |
| 821 |
HYPERTENSION |
16 |
0.0001 |
| 822 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 823 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 824 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 825 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 826 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 827 |
ASTHENIA |
27 |
0.0001 |
| 828 |
APHONIA |
1 |
0.0001 |
| 829 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 830 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 831 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 832 |
MALAISE |
31 |
0.0001 |
| 833 |
MUSCULAR WEAKNESS |
8 |
0.0001 |
| 834 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 835 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 836 |
GASTROENTERITIS |
1 |
0.0001 |
| 837 |
UNDERDOSE |
5 |
0.0001 |
| 838 |
COVID-19 |
12 |
0.0001 |
| 839 |
ASCITES |
2 |
0.0001 |
| 840 |
RENAL FAILURE |
9 |
0.0001 |
| 841 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 842 |
DYSGEUSIA |
5 |
0.0001 |
| 843 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 844 |
THROAT IRRITATION |
3 |
0.0001 |
| 845 |
BONE LOSS |
1 |
0.0001 |
| 846 |
PREMATURE BABY |
2 |
0.0001 |
| 847 |
INCORRECT DOSE ADMINISTERED |
15 |
0.0001 |
| 848 |
VERTIGO |
4 |
0.0001 |
| 849 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 850 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 851 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 852 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 853 |
ANKLE FRACTURE |
1 |
0.0001 |
| 854 |
DELUSION |
1 |
0.0001 |
| 855 |
INFLUENZA |
7 |
0.0001 |
| 856 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 857 |
SWELLING FACE |
4 |
0.0001 |
| 858 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 859 |
HEART RATE INCREASED |
6 |
0.0001 |
| 860 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 861 |
COAGULOPATHY |
1 |
0.0001 |
| 862 |
SKIN DISORDER |
2 |
0.0001 |
| 863 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 864 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 865 |
DELIRIUM |
2 |
0.0001 |
| 866 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 867 |
COLD SWEAT |
1 |
0.0001 |
| 868 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 869 |
GOUT |
1 |
0.0001 |
| 870 |
DRUG EFFECT DECREASED |
3 |
0.0001 |
| 871 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 872 |
ARTHROPATHY |
3 |
0.0001 |
| 873 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 874 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 875 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 876 |
FOOT FRACTURE |
1 |
0.0001 |
| 877 |
EYE IRRITATION |
3 |
0.0001 |
| 878 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 879 |
ERUCTATION |
1 |
0.0001 |
| 880 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 881 |
NASAL CONGESTION |
3 |
0.0001 |
| 882 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 883 |
DISABILITY |
1 |
0.0001 |
| 884 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 885 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 886 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 887 |
BLINDNESS |
2 |
0.0000 |
| 888 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 889 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 890 |
ERYTHEMA |
10 |
0.0000 |
| 891 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 892 |
CARDIAC ARREST |
4 |
0.0000 |
| 893 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 894 |
DERMATITIS |
1 |
0.0000 |
| 895 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 896 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 897 |
PRODUCT STORAGE ERROR |
4 |
0.0000 |
| 898 |
PAIN |
28 |
0.0000 |
| 899 |
HOSPITALISATION |
7 |
0.0000 |
| 900 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 901 |
PARAESTHESIA |
7 |
0.0000 |
| 902 |
ASTHMA |
5 |
0.0000 |
| 903 |
NASOPHARYNGITIS |
8 |
0.0000 |
| 904 |
CHEST PAIN |
8 |
0.0000 |
| 905 |
RENAL DISORDER |
2 |
0.0000 |
| 906 |
CARDIAC DISORDER |
4 |
0.0000 |
| 907 |
DYSPNOEA |
24 |
0.0000 |
| 908 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 909 |
NEUROPATHY PERIPHERAL |
4 |
0.0000 |
| 910 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 911 |
CONTUSION |
4 |
0.0000 |
| 912 |
BRONCHITIS |
3 |
0.0000 |
| 913 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 914 |
ACNE |
3 |
0.0000 |
| 915 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
8 |
0.0000 |
| 916 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 917 |
COUGH |
11 |
0.0000 |
| 918 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 919 |
PERIPHERAL SWELLING |
6 |
0.0000 |
| 920 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
7 |
0.0000 |
| 921 |
DEAFNESS |
1 |
0.0000 |
| 922 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 923 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 924 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 925 |
NEUTROPENIA |
5 |
0.0000 |
| 926 |
CONSTIPATION |
8 |
0.0000 |
| 927 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 928 |
COMPLETED SUICIDE |
3 |
0.0000 |
| 929 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 930 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 931 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 932 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 933 |
CHILLS |
4 |
0.0000 |
| 934 |
SURGERY |
2 |
0.0000 |
| 935 |
JOINT SWELLING |
4 |
0.0000 |
| 936 |
CYSTITIS |
1 |
0.0000 |
| 937 |
ARTHRALGIA |
13 |
0.0000 |
| 938 |
PRURITUS |
12 |
0.0000 |
| 939 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 940 |
GAIT INABILITY |
1 |
0.0000 |
| 941 |
EYE PRURITUS |
1 |
0.0000 |
| 942 |
SINUSITIS |
3 |
0.0000 |
| 943 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 944 |
HAEMORRHAGE |
3 |
0.0000 |
| 945 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 946 |
MOBILITY DECREASED |
2 |
0.0000 |
| 947 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 948 |
EYE SWELLING |
1 |
0.0000 |
| 949 |
HYPOAESTHESIA |
4 |
0.0000 |
| 950 |
HOT FLUSH |
2 |
0.0000 |
| 951 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 952 |
DIABETES MELLITUS |
2 |
0.0000 |
| 953 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 954 |
PALPITATIONS |
3 |
0.0000 |
| 955 |
ARTHRITIS |
2 |
0.0000 |
| 956 |
DRUG DEPENDENCE |
4 |
0.0000 |
| 957 |
PROSTATE CANCER |
2 |
0.0000 |
| 958 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 959 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 960 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 961 |
BREAST CANCER |
2 |
0.0000 |
| 962 |
SWELLING |
2 |
0.0000 |
| 963 |
INFECTION |
3 |
0.0000 |
| 964 |
CELLULITIS |
1 |
0.0000 |
| 965 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 966 |
ECZEMA |
1 |
0.0000 |
| 967 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 968 |
DRUG DOSE OMISSION |
3 |
0.0000 |
| 969 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 970 |
SEPSIS |
2 |
0.0000 |
| 971 |
EYE PAIN |
1 |
0.0000 |
| 972 |
BONE PAIN |
1 |
0.0000 |
| 973 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 974 |
DISCOMFORT |
1 |
0.0000 |
| 975 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 976 |
DRY SKIN |
2 |
0.0000 |
| 977 |
BURNING SENSATION |
1 |
0.0000 |
| 978 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 979 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 980 |
DEATH |
11 |
0.0000 |
| 981 |
CARDIAC FAILURE |
1 |
0.0000 |
| 982 |
DRY MOUTH |
1 |
0.0000 |
| 983 |
DRUG ABUSE |
1 |
0.0000 |
| 984 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 985 |
MYALGIA |
2 |
0.0000 |
| 986 |
MUSCLE SPASMS |
2 |
0.0000 |
| 987 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 988 |
FLUSHING |
1 |
0.0000 |
| 989 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 990 |
INJECTION SITE PAIN |
2 |
0.0000 |